TELA Bio grants new CEO Heather Getz stock options for 2,370,000 shares, 500,000 RSUs

• TELA Bio set inducement equity awards for new CEO Heather Getz, dated Aug. 3, 2026.
• Grant includes options for 2,370,000 shares, split into 1,365,000 standard options at $0.74 and 1,005,000 premium-priced options at $0.9.
• Options run 10 years; 25% vests on the first anniversary; remainder vests monthly over the next 36 months, subject to continued service.
• Getz also received restricted stock units for 500,000 shares, vesting in equal annual installments over four years.
• Separate inducement RSUs for 95,500 shares were granted to 11 newly hired employees, dated Aug. 4, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608051605PRIMZONEFULLFEED9804278) on August 05, 2026, and is solely responsible for the information contained therein.